210 related articles for article (PubMed ID: 35003886)
21. [
Hong H; Zha Z; Zhao R; Luo Y; Jin W; Li L; Wang R; Yan L; Wang H; Ploessl K; Qiao J; Zhu L; Kung HF
Mol Pharm; 2023 Apr; 20(4):2159-2169. PubMed ID: 36942924
[TBL] [Abstract][Full Text] [Related]
22. Clinical translation of a novel FAPI dimer [
Tan Y; Li J; Zhao T; Zhou M; Liu K; Xiang S; Tang Y; Jakobsson V; Xu P; Chen X; Zhang J
Eur J Nucl Med Mol Imaging; 2024 Apr; ():. PubMed ID: 38561515
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Poly(ADP-ribose) Polymerase Sensitizes [
Bao G; Zhou H; Zou S; Chen L; Zhang B; Wang Z; Moon ES; Zhao J; Roesch F; Zhu X
Mol Pharm; 2023 May; 20(5):2443-2451. PubMed ID: 37067162
[TBL] [Abstract][Full Text] [Related]
24. Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy.
Xu M; Zhang P; Ding J; Chen J; Huo L; Liu Z
J Nucl Med; 2022 Jun; 63(6):952-958. PubMed ID: 34593598
[TBL] [Abstract][Full Text] [Related]
25. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [
Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S
Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677
[TBL] [Abstract][Full Text] [Related]
26. Translational assessment of a DATA-functionalized FAP inhibitor with facile
Escudero-Castellanos A; Kurth J; Imlimthan S; Menéndez E; Pilatis E; Moon ES; Läppchen T; Rathke H; Schwarzenböck SM; Krause BJ; Rösch F; Rominger A; Gourni E
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3202-3213. PubMed ID: 37284857
[TBL] [Abstract][Full Text] [Related]
27. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a
Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA
J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922
[TBL] [Abstract][Full Text] [Related]
28. Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides.
Millul J; Koepke L; Haridas GR; Sparrer KMJ; Mansi R; Fani M
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3050-3061. PubMed ID: 37261473
[TBL] [Abstract][Full Text] [Related]
29. [
Ballal S; Yadav MP; Raju S; Roesch F; Martin M; Tripathi M; Bal C
Nucl Med Mol Imaging; 2024 Feb; 58(1):32-34. PubMed ID: 38261876
[TBL] [Abstract][Full Text] [Related]
30. Improved cancer detection in Waldeyer's tonsillar ring by
Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
[TBL] [Abstract][Full Text] [Related]
31. Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy.
Zhang P; Xu M; Ding J; Chen J; Zhang T; Huo L; Liu Z
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1985-1996. PubMed ID: 34746969
[TBL] [Abstract][Full Text] [Related]
32.
Li H; Ye S; Li Li ; Zhong J; Yan Q; Zhong Y; Feng P; Hu K
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2705-2715. PubMed ID: 35290473
[TBL] [Abstract][Full Text] [Related]
33. Design and Development of
Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
[TBL] [Abstract][Full Text] [Related]
34. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
35. Non-invasive visualization of liver fibrosis with [
Song Y; Qin C; Chen Y; Ruan W; Gai Y; Song W; Gao Y; Hu W; Qiao P; Song X; Lv X; Zheng D; Chu H; Jiang D; Yang L; Lan X
Eur J Nucl Med Mol Imaging; 2024 Jun; ():. PubMed ID: 38850311
[TBL] [Abstract][Full Text] [Related]
36. From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [
Greifenstein L; Kramer CS; Moon ES; Rösch F; Klega A; Landvogt C; Müller C; Baum RP
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015148
[TBL] [Abstract][Full Text] [Related]
37. Detecting Fibroblast Activation Proteins in Lymphoma Using
Jin X; Wei M; Wang S; Wang G; Lai Y; Shi Y; Zhang Y; Yang Z; Wang X
J Nucl Med; 2022 Feb; 63(2):212-217. PubMed ID: 34049984
[TBL] [Abstract][Full Text] [Related]
38. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
Watabe T; Liu Y; Kaneda-Nakashima K; Shirakami Y; Lindner T; Ooe K; Toyoshima A; Nagata K; Shimosegawa E; Haberkorn U; Kratochwil C; Shinohara A; Giesel F; Hatazawa J
J Nucl Med; 2020 Apr; 61(4):563-569. PubMed ID: 31586001
[TBL] [Abstract][Full Text] [Related]
39. SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.
Luo X; Zhang Z; Cheng C; Wang T; Fang D; Zuo C; Yuan G; Li R; Li X
Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986521
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies.
Privé BM; Boussihmad MA; Timmermans B; van Gemert WA; Peters SMB; Derks YHW; van Lith SAM; Mehra N; Nagarajah J; Heskamp S; Westdorp H
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1906-1918. PubMed ID: 36813980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
